Organic Acidurias and Related Abnormalities

References

• Scriver C. R., Beaudet A. L., Sly W. S., et al. The metabolic basis of inherited disease.6th ed. McGraw Hill, New York 1989
   Google Scholar
• Sweetman L. Qualitative and quantitative analysis of organic acids in physiologic fluids for diagnosis of the organic acidurias. Abnormalities in amino acid metabolism in clinical medicine, W. L. Nyhan. Appleton-Century-Crofts, Norwalk 1984; 419–53
   Google Scholar
• Cherrington C. A., Hinton M., Mead G. C., et al. Organic acids: chemistry, antibacterial activity and practical applications. Adv Microb Physiol 1991; 32: 87–107
   PubMed Web of Science ®Google Scholar
• Greenway DLA, Dyke KGH. Mechanism of the inhibitory action of linoleic acid on the growth of. Staphylococcus aureus. J Gen Microbiol 1979; 155: 233–45
   Google Scholar
• Van Pilsum J. F. Metabolism of individual tissues. Textbook of biochemistry, T. M. Devlin. John Wiley & Sons, New York 1982; 1001
   Google Scholar
• Bremer J., Osmundsen H. Fatty acid oxidation and its regulation. Fatty acid metabolism and its regulation, S. Numa. Elsevier, Amsterdam 1984; 113
   Google Scholar
• Mannaerts G. P., Van Veldhoven P. P. Fatty acid oxidation: general overview. Inborn errors of metabolism, J. Schaub, F. Van Hoof, H. L. Vis. Raven Press, New York 1991; 1–18
   Google Scholar
• Stanley C. A. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency. Adv Pediatr 1987; 35: 59–88
   Google Scholar
• Kim C. S., O'Tuamala L. A., Mann J. D., et al. Effect of increasing carbon chain-length on organic acid transport by the choroid plexus: a potential factor in Reye's syndrome. Brain Res. 1983; 259: 340–3
   PubMedGoogle Scholar
• Kim C. S., Roe C. R., Mann J. D., et al. Octanoic acid produces accumulation of monoamine acidic metabolites in the brain: interaction with organic anion transport at the choroid plexus. J Neurochem 1992; 58: 1499–1503
   PubMedGoogle Scholar
• Trauner D. Regional cerebral Na+-K+-ATPase activity following octanoate administration. Pediatr Res 1980; 14: 844–5
   PubMedGoogle Scholar
• Duran M., Mitchell G., De Klerk JBC, et al. Octanoic acidemia and octanoylcamitine excretion with dicarboxylic aciduria due to defective oxidation of medium-chain fatty acids. J Pediatr. 1985; 107: 397–404
   PubMedGoogle Scholar
• Tanaka K., Budd M. A., Efron M. L., et al. Isovaleric acidemia: a new genetic defect of leucine metabolism. Proc Natl Acad Sci USA 1966; 56: 236–42
   PubMed Web of Science ®Google Scholar
• Sweetman L. Qualitative and quantitative analysis of organic acids in physiological fluids for diagnosis of organic acidurias. Abnormalities in amino acid metabolism in clinical medicine, W. L. Nyhan. Appleton-Century-Crofts, Norwalk 1984
   Google Scholar
• Horning E. C., Homing M. G. Metabolic profiles: gas phase methods for analysis of metabolites. Clin Chem 1971; 17: 802–9
   PubMed Web of Science ®Google Scholar
• Horning E. C., Homing M. G., Szafranek J., et al. Gas phase analytical methods for the study of human metabolites. Metabolic profiles obtained by open tubular capillary chromatography. J Chromatogr. 1974; 91: 367–78
   PubMedGoogle Scholar
• Chalmers R. A., Lawson A. M. Organic acids in man. Chapman and Hall, New York 1982
   Google Scholar
• Goodman S. I., Markey S. P. Diagnosis of organic acidemias by gas chromatography mass spectrometry. Lab Res Methods Biol Med. 1981; 6: 1–42
   PubMedGoogle Scholar
• Goodman S. I. An introduction to gas chromatography-mass spectrometry and the inherited organic acidemias. Am J Hum Genet. 1980; 32: 781–92
   PubMedGoogle Scholar
• Hoffman G., Aramaki S., Blum-Hoffman E., et al. Quantitative analysis for organic acid analysis in biological samples: batch isolation followed by gas chromatographic-mass spectrometric analysis. Clin Chem 1989; 35: 587–95
   PubMed Web of Science ®Google Scholar
• Tanaka K., Hine D. G., West-Dull A., et al. Gas-chromatographic method for urinary organic acids. I. Retention Indices for 155 metabolically important compounds. Clin Chem. 1980; 26: 1839–46
   PubMed Web of Science ®Google Scholar
• Tanaka K., West-Dull A., Hine D. G., et al. Gas chromatographic method of analysis for urinary organic acids. II. Description of the procedure, and its application to diagnosis of patients with organic acidurias. Clin Chem. 1980; 26: 1947–53
   Google Scholar
• Lawson A. M., Chalmers RA, Watts RWE. Urinary organic acids in man. I. Normal patterns. Clin Chem. 1976; 22: 1283–7
   PubMedGoogle Scholar
• Chalmers R. A., Healy MJR, Lawson A. M., et al. Urinary organic acids in man. II. Effects of individual variation and diet on the urinary excretion of acidic metabolites. Clin Chem. 1976; 22: 1288–91
   PubMed Web of Science ®Google Scholar
• Chalmers R. A., Healy MJR, Lawson A. M., et al. Urinary organic acids in man. III. Quantitative ranges and patternsofexcretion in a normal population. Clin Chem. 1976; 22: 1292–8
   PubMed Web of Science ®Google Scholar
• Thompson J. A., Markey S. P. Quantitative metabolic profiling of urinary organic acids by gas chromatography-mass spectrometry: comparison of isolation methods. Anal Chem 1975; 47: 1313–21
   PubMed Web of Science ®Google Scholar
• Holland J. F., Leary JJ, Sweeley C. S. Advanced instrumentation and strategies for metabolic profiling. J Chromatogr 1986; 379: 3–26
   PubMedGoogle Scholar
• Niwa T. Metabolic profiling with gas chromatography-mass spectrometry and its application to clinical medicine. J Chromatogr. 1986; 379: 313–45
   PubMedGoogle Scholar
• Jellum E., Thorensen O., Horn L., et al. Advances in the use of computerized gas chromatography-mass spectrometry and high-performance liquid chromatography with rapid scanning detection for clinical diagnosis. J Chromatogr. 1989; 468: 43–53
   PubMedGoogle Scholar
• Tuchman M., McCann M. T., Johnson P. E., et al. Screening newborns for multiple organic acidurias in dried filter paper urine samples: method development. PediatrRes. 1991; 30: 315–21
   Google Scholar
• Liebich H. M. Basic profiles for organic acids in urine. J Chromatogr. 1990; 525: 1–14
   PubMedGoogle Scholar
• Shoemaker J. D., Elliott W. H. Automated screening of urine samples for carbohydrates, organic and amino acids after treatment with urease. J Chromatogr. 1991; 562: 125–38
   PubMed Web of Science ®Google Scholar
• Lehotay D. C. Chromatographic techniques in inborn errors of metabolism. Biomed Chromatogr. 1991; 5: 113–21
   PubMedGoogle Scholar
• Bieber L. L., Lewin L. M. Measurement of carnitine and O-acylcamitines. Methods Enzymol. 1981; 72: 276–87
   PubMedGoogle Scholar
• Hosokawa Y., Shimomura Y., Harris R. A., et al. Determination of short-chain acyl-Coenzyme A esters by high-performance liquid chromatography. Anal Biochem. 1986; 153: 45–9
   PubMedGoogle Scholar
• Hoppel C. L., Brass E. P., Gibbons A. P., et al. Separation of acylcamitines from biological samples using high-performance liquid chromatography. Anal Biochem 1986; 156: 111–7
   PubMedGoogle Scholar
• Roe C. R., Millington DS, Maltby D. A. Clinical aspects of human carnitine deficiency, P. R. Borum. Pergamon Press, New York 1985; 97–107
   Google Scholar
• Millington D. S., Norwood D. L., Kodo N., et al. Application of fast atom bombardment with tandem mass spectrometry and liquid chromatography to the analysis of acylcamitines in human urine, blood, and tissue. Anal Biochem 1989; 180: 331–9
   PubMed Web of Science ®Google Scholar
• Millington D. S., Terado N., Chase D. H., et al. The role of tandem mass spectrometry in the diagnosis of fatty acid oxidation disorders. Prog Clin Biol Res. 1992; 375: 339–54
   PubMedGoogle Scholar
• Yergey A. L., Liberato DJ, Millington D. S. Thermospray liquid chromatography/mass spectrometry for the analysis of L-camitine and its short-chain acyl derivatives. Anal Biochem. 1984; 139: 278–83
   PubMedGoogle Scholar
• Rashed M. S., Ozand P. T., Harrison M. E., et al. Electrospray tandem mass spectrometry in the diagnosis of organic acidemias. Rapid Commun Mass Spectrom. 1994; 8: 129–33
   Google Scholar
• Lowes S., Rose M. E. Simple and unambiguous method for identifying urinary acylcamitines using gas chromatography-mass spectrometry. Analyst. 1990; 115: 511–16
   PubMedGoogle Scholar
• Lowes S., Rose M. E., Mills G. A., et al. Identification of urinary acylcamitines using gas chromatography-mass spectrometry: preliminary clinical applications. J Chromatogr. 1992; 577: 205–14
   PubMedGoogle Scholar
• Huang Z. H., Gage D. A., Bieber L. R., et al. Analysis of acylcamitines as their A'-demethylated ester derivatives by gas chromatography-chemical ionization mass spectrometry. Anal Biochem. 1991; 199: 98–105
   PubMedGoogle Scholar
• Huang Z. H., Sweeley C. C., Bieber L. L., et al. A general method for the simultaneous analysis of free carnitine and acylcamitines by GC-MS of their /V-methylated silylated derivatives. Presented at the 1992 meeting of the ASMS, Nashville, TN. 1992
   Google Scholar
• Rinaldo P., O'Shea J. J., Coates P. M., et al. Medium-chain acyl-CoA dehydrogenase deficiency: diagnosis by stable isotope dilution measurement of urinary n-hexanoylglycine and 3-phenylpropionylglycine. N Engl J Med 1988; 319: 1308–13
   PubMed Web of Science ®Google Scholar
• Rinaldo P., O'Shea J. J., Goodman S. I., et al. Comparison of urinary acylglycines and acylcamitines as diagnostic markers of medium-chain acyl-CoA dehydrogenase deficiency. J Inherited Metab Dis 1989; 12(suppl 2)325–8
   PubMedGoogle Scholar
• Bennett M. J., Bhala A., Poirier S. F., et al. When does gut flora in the newborn produce 3-phenylpropionic acid? Implications for the early diagnosis of the medium-chain acyl-CoA dehydrogenase (MCAD) deficiency. Clin Chem. 1992; 38: 278–81
   PubMed Web of Science ®Google Scholar
• Bhala A., Bennett M. J., McGowan K. L., et al. Limitations of 3-phenylpropionylglycine in early screening for medium-chain acyl-coenzyme A dehydrogenase deficiency. J Pediatr. 1993; 122: 100–3
   PubMed Web of Science ®Google Scholar
• Rumsby G., Seakins JWT, Leonard J. V. A simple screening test for medium-chain acyl-CoA dehydrogenase deficiency. Lancet. 1986; 2: 467
   PubMedGoogle Scholar
• Hommes F. A., Blitzer M. G., Brewster M. A., et al. Proficiency testing for biochemical genetics laboratories: the first 10 rounds of testing. Am J Hum Genet 1990; 46: 1001
   PubMedGoogle Scholar
• Bonham J. R., Downing M., Pollit R. J., et al. Quality assessment of urinary organic acid analysis. Ann Clin Biochem. 1994; 31: 129–33
   PubMedGoogle Scholar
• Bennett M. J., Ragni M. C., Hood I., et al. Azelaic and pimelic acids: metabolic intermediates or artefacts. J Inherited Metab Dis. 1992; 15: 220–3
   PubMedGoogle Scholar
• Walker V., Mills G. A., Hall M. A., et al. Carbohydrate fermentation by gut microflora in preterm neonates. Arch Dis Child 1989; 64: 1367–73
   PubMedGoogle Scholar
• Shoemaker J. D., Lynch R. E., Hoffmann J. W., et al. Misidentification of propionic acid as ethylene glycol in a patient with methylmalonic acidemia. J Pediatr 1992; 120: 417–21
   PubMed Web of Science ®Google Scholar
• Woolf A. D., Wynshaw-Boris A., Rinaldo P., et al. Intentional infantile ethylene glycol poisoning presenting as an inherited metabolic disorder. J Pediatr. 1992; 120: 421–4
   PubMedGoogle Scholar
• Saudubray J. M., Ogier H. Clinical approach to inherited metabolic disorders. Inborn metabolic diseases, J. Fernandes, J. M. Saudubray, K. Tada. Springer-Verlag, Berlin 1990; 3–25
   Google Scholar
• Ozand P. T., Gascon G. G. Organic acidurias: a review, Part 1. J Child Neurol 1991; 6: 196–219
   PubMedGoogle Scholar
• Robinson B. H. Lacticacidemia. Biochim Biophys Acta Mol Basis Dis. 1993; 1182: 231–44
   PubMedGoogle Scholar
• Danner D. J., Elsas I LJ. Disorders of branched chain amino acid and keto acid metabolism. The metabolic basis of inherited disease.6th ed., C. R. Scriver, A. L. Beaudet, W. S. Sly, et al. McGraw-Hill, New York 1989; 671–92
   Google Scholar
• Sweetman L. Branched chain organic acidurias. The metabolic basis of inherited disease.6th ed., C. R. Scriver, A. L. Beaudet, W. S. Sly, et al. McGraw-Hill, New York 1989; 791–819
   Google Scholar
• Leonard J. V., Seakins JWT, Bartlett K., et al. Inherited disorders of 3-methylcrotonyl CoA carboxylation. Arch Dis Child 1981; 56: 53–9
   PubMedGoogle Scholar
• Sweetman L., Nyhan W. L. Inheritable biotin-treatable disorders and associated phenomena. Annu Rev Nutr. 1986; 6: 317–43
   PubMedGoogle Scholar
• Wolf B., Grier R. E., Allen R. J., et al. Biotinidase deficiency: the enzymatic defect in late-onset multiple carboxylase deficiency. Clin ChimActa. 1983; 131: 272–81
   Google Scholar
• Gibson K. M., Elpeleg O. N., Jakobs C., et al. Multiple syndromes of 3-methylglutaconic aciduria. Pediatr Neurol. 1993; 9: 120–3
   PubMedGoogle Scholar
• Duran M., Walther FJ, Bruinvis L., et al. The urinary excretion of ethylmalonic acid: what level requires further attention%. Biochem Med 1983; 29: 171–5
   PubMedGoogle Scholar
• Costeff H., Elpeleg O., Apter N., et al. 3-Methylglutaconic aciduria in optic atrophy plus. Ann Neurol 1993; 33: 103–41
   PubMedGoogle Scholar
• Costeff H., Gadoth N., Apter N, et al. A familial syndrome of infantile optic atrophy, movement disorder, and spastic paraplegia. Neurology 1989; 39: 595–7
   PubMedGoogle Scholar
• Chitayat D, Chemke J., Gibson K. M., et al. 3-Methylglutaconic aciduria: a marker for as yet unspecified disorders and the relevance of prenatal diagnosis in a 'new' type ('type 4'). J Inherited Metab Dis. 1992; 15: 204–12
   PubMedGoogle Scholar
• Gibson K. M., Sherwood W. G., Hoffmann G. F., et al. Phenotypic heterogeneity in the syndromes of 3-methylglutaconic aciduria. J Pediatr. 1991; 118: 885–90
   PubMedGoogle Scholar
• Holme E., Greter J., Jacobson C. E., et al. Mitochondrial ATP-synthase deficiency in a child with 3-methylglutaconic aciduria. Pediatr Res. 1992; 32: 731–5
   PubMedGoogle Scholar
• Ibel H., Endres W., Hadom H-B, et al. Multiple respiratory chain abnormalities associated wim hypertrophic cardiomyopathy and 3-methylglutaconic aciduria. Eur J Pediatr. 1993; 152: 665–70
   PubMedGoogle Scholar
• Muller-Hocker J., Ibel H., Paetzke I., et al. Fatal infantile mitochondria] cardiomyopathy and myopathy with heterogeneous tissue expression of combined respiratory chain deficiencies. Virchows Arch [A]. 1991; 419: 355–62
   Google Scholar
• Lichter-Konecki U., Trefz F. K., Rotig A., et al. 3-Methylglutaconic aciduria in a patient with Pearson syndrome. Eur J Pediatr. 1993; 152: 378–9
   PubMed Web of Science ®Google Scholar
• Hammond J., Wilcken B. 3-Hydroxy-3-methylglutaric, 3-methylglutaconic, and 3-methylgIutaric acids can be non-specific indicators of metabolic disease. J Inherited Metab Dis 1984; 7(Suppl 12)117–8
   PubMedGoogle Scholar
• Gibson K. M., Breuer J, Nyhan W. L. 3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: review of 18 reported patients. Eur J Pediatr. 1988; 148: 180–6
   PubMedGoogle Scholar
• Wysocki S. J., Hahnel R. 3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: a review. J Inherited Metab Dis. 1986; 9: 225–33
   PubMed Web of Science ®Google Scholar
• Faull K. F., Bolton P. D., Halpern B., et al. The urinary organic acid profile associated with 3-hydroxy-3-methyl glutaric aciduria. Clin ChimActa 1976; 73: 553–9
   PubMed Web of Science ®Google Scholar
• Duran M., Ketting D., Wadman SK, et al. Organic acid excretion in a patient with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency: facts and artefacts. Clin ChimActa 1978; 90: 187–93
   PubMedGoogle Scholar
• Roe C. R., Millington DS, Maltby D. A. Identification of 3-methylglutarylcarnitine. A new diagnostic metabolite of 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency. J Clin Invest 1986; 77: 1391–4
   PubMedGoogle Scholar
• Massoud A. F., Leonard J. V. Cardiomyopathy in propionic acidemia. Eur J Pediatr. 1993; 152: 441–5
   PubMedGoogle Scholar
• Rosenberg L. E., Fenton W. A. Disorders of propionate and methylmalonate metabolism. The metabolic basis of inherited disease, C. R. Scriver, A. L. Beaudet, W. S. Sly, et al. McGraw-Hill, New York 1989; 822–44
   Google Scholar
• Ledley F. D., Crane AM, Lumetta M. Heterogeneous alleles and expression of methylmalonyl CoA mutase in mut methylmalonic acidemia. Am J Hum Genet 1990; 46: 539–47
   PubMedGoogle Scholar
• Ledley F. D., Levy H. L., Shih V. E., et al. Benign methylmalonic aciduria. N Engl J Med. 1984; 311: 1015–8
   PubMedGoogle Scholar
• Ando T., Rasmussen K., Wright J. M., et al. Isolation and identification of methylcitrate, a major metabolic product of propionate in propionic acidemia. J Biol Chem. 1972; 247: 2200–4
   PubMed Web of Science ®Google Scholar
• Rosenblatt D. S., Cooper B A. Inherited disorders of vitamin Butilization. Bioessays. 1990; 12: 331–4
   PubMed Web of Science ®Google Scholar
• Haworth J. C., Booth F. A., Chudley A. E., et al. Phenotypic variability in glutaric aciduria type I: report of fourteen cases in five Canadian Indian kindreds. J Pediatr. 1991; 118: 52–8
   PubMedGoogle Scholar
• Campistol J., Ribes A., Alvarez L., et al. Glutaric aciduria type I; unusual biochemical presentation. J Pediatr. 1992; 121: 83–6
   PubMedGoogle Scholar
• Frerman F. E., Goodman S. I. Glutaric acidemia type II and defects of the mitochondrial respiratory chain. The metabolic basis of inherited disease, C. R. Scriver, A. L. Beaudet, W. S. Sly, et al. McGraw-Hill, New York 1989; 915–31
   Google Scholar
• Amendt B. A., Rhead W. J. The multiple acyl-coenzyme A dehydrogenation disorders, glutaric aciduria type II and ethylmalonic-adipic aciduria: mitochondrial fatty acid oxidation, acyl-coenzyme A dehydrogenase, and electron transfer flavoprotein activities in fibroblasts. J Clin Invest 1986; 78: 205–13
   PubMedGoogle Scholar
• Frerman F., Goodman S. Deficiency of electron transfer flavoprotein or electron transfer flavoprotein: ubiquinone oxidoreductase in glutaric acidemia II fibroblasts. Proc Natl Acad Sci USA 1985; 82: 4517–20
   PubMed Web of Science ®Google Scholar
• Barth P. G., Hoffmann G. F., Jaeken J., et al. L-2-Hydroxyglutaric acidaemia: clinical and biochemical findings in 12 patients and preliminary report on L-2-hydroxyacid dehydrogenase. J Inherited Metab Dis 1993; 16: 753–61
   PubMed Web of Science ®Google Scholar
• Gibson K. M., Craigen W., Herman G. E. D-2-Hydroxyglutaric aciduria in a newborn with neurological abnormalities: a new neurometabolic disorder. J Inherited Metab dis 1993; 16: 497–500
   PubMed Web of Science ®Google Scholar
• Rating D., Hanefeld F., Siemens H., et al. 4-Hydroxybutyric aciduria: a new inborn error of metabolism. I. Clinical review. J. Inherited Metab Dis. 1984; 7: 90–1
   PubMed Web of Science ®Google Scholar
• Jacobs C., Kneer J, Rating D., et al. Hydroxybutyric aciduria: a new inborn error of metabolism. II. Biochemical findings. J Inherited Metab Dis. 1984; 7: 92
   PubMedGoogle Scholar
• Gibson K. M., Jansen I., Sweetman L., et al. 4-Hydroxybutyric aciduria: a new inborn error of metabolism. III. Enzymology and inheritance. J Inherited Metab Dis. 1984; 7: 95–9
   PubMedGoogle Scholar
• Matalon R., Michaels K., Kaul R., et al. Malonic aciduria and cardiomyopathy. J Inherited Metab Dis 1993; 16: 571–3
   PubMed Web of Science ®Google Scholar
• Sewell A. C., Herwig J., Bohles H., et al. A new case of short-chain acyl-CoA dehydrogenase deficiency with isolated ethylmalonic aciduria. Eur J Pediatr. 1993; 152: 922–4
   PubMed Web of Science ®Google Scholar
• Burlina A. B., Dionisi-Vici C., Bennett M. J., et al. A new syndrome with ethylmalonic aciduria and normal fatty acid oxidation in fibroblasts. J Pediatr. 1994; 124: 79–86
   PubMedGoogle Scholar
• Garavaglia B., Colamaria V., Carrara F., et al. Muscle cytochrome c oxidase deficiency in two Italian patients with ethylmalonic aciduria and peculiar clinical phenotype. J Inherited Metab Dis 1994; 17: 301–3
   PubMedGoogle Scholar
• Christensen E., Brandt N. J., Schmalbruch H., et al. Muscle cytochrome C oxidase deficiency accompanied by a urinary organic acid pattern mimicking multiple acyl-CoA dehydrogenase deficiency. J Inherited Metab Dis 1993; 16: 553–6
   PubMedGoogle Scholar
• Lehnert W., Ruitenbeek W. Ethylmalonic aciduria associated with progressive neurological disease and partial cytochrome C oxidase deficiency. J Inherited Metab Dis 1993; 16: 557–9
   PubMedGoogle Scholar
• Duran M., Walther F. J., Bruinvis L., et al. The urinary excretion of ethylmalonic acid: what level requires further attention%. Biochem Med 1983; 29: 171–5
   PubMedGoogle Scholar
• Kay M. A., O'Brien W., Kessler B., et al. Transient organic aciduria and methemoglobinuria with acute gastroenteritis. Pediatrics 1990; 85: 589–92
   PubMedGoogle Scholar
• Whelan D. T., Hill RE, McClorry S. Fumaric aciduria: a new organic aciduria, associated with mental retardation and speech impairment. Clin Chim Acta. 1983; 132: 301–8
   PubMedGoogle Scholar
• Lindblad B., Lindstedt S, Steen G. On the enzymic defects in hereditary tyrosinemia. Proc Natl AcadSci USA 1977; 74: 4641–5
   PubMed Web of Science ®Google Scholar
• Kvittingen E. A. Hereditary tyrosinemia type I: an overview. Scand J Clin Lab Invest 1986; 46(Suppl 146)27–34
   PubMedGoogle Scholar
• Lindstedt S., Holme E., Lock E. A., et al. Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet. 1992; 340: 813–7
   PubMed Web of Science ®Google Scholar
• Hillman R. E. Primary hyperoxalurias. The metabolic basis of inherited disease, C. R. Scriver, A. L. Beaudet, W. S. Sly, et al. McGraw-Hill, New York 1989; 933–44
   Google Scholar
• Wandzilak T. R., Williams H. E. The hyperoxaluric syndromes. Endocrinol Metab Clin North Am 1990; 19: 851–67
   PubMedGoogle Scholar
• Danpure C. J., Jennings P. R. Peroxisomal alanine: glyoxylate aminotransferase deficiency in primary hyperoxaluria type I. FEBS Lett. 1986; 201: 20–4
   PubMed Web of Science ®Google Scholar
• Matalon R., Michals K., Sebesta D., et al. Aspartoacylase deficiency and /V-acetylaspartic aciduria in patients with Canavan disease. Am J Med Genet 1988; 29: 463–71
   PubMedGoogle Scholar
• Rhead W. J. Inborn errors of fatty acid oxidation in man. Clin Biochem. 1991; 24: 319–29
   PubMedGoogle Scholar
• Vianey-Liaud C., Divry P., Gregersen N., et al. The inborn errors of mitochondrial fatty acid oxidation. J Inherited Metab Dis 1987; 10(suppl 1)159–98
   PubMed Web of Science ®Google Scholar
• Hale D. E., Bennett M. J. Fatty acid oxidation disorders: a new class of metabolic diseases. J Pediatr. 1992; 121: 1–11
   PubMedGoogle Scholar
• Jackson S., Kler R. S., Bartlett K., et al. Combined enzyme defect of mitochondrial fatty acid oxidation. J Clin Invest 1992; 90: 1219–25
   PubMedGoogle Scholar
• Morton D. H., Kelley R. I. Diagnosis of medium-chain acyl-coenzyme A dehydrogenase deficiency in the neonatal period by measurement of medium-chain fatty acids in plasma and filter paper blood samples. J Pediatr. 1990; 117: 439–42
   PubMedGoogle Scholar
• Roe C. R., Coates P. M. Acyl-CoA dehydrogenase deficiencies. The metabolic basis of inherited disease, C. R. Scriver, A. L. Beaudet, W. S. Sly, et al. McGraw-Hill, New York 1989; 889–994
   Google Scholar
• Stanley C. A., Hale D. E., Coates P. M., et al. Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels. Pediatr Res. 1983; 17: 877–84
   PubMed Web of Science ®Google Scholar
• Taubman B., Hale DE, Kelley R. I. Familial Reye-like syndrome: a presentation of medium-chain acyl-coenzyme A deficiency. Pediatrics. 1987; 79: 382–5
   PubMedGoogle Scholar
• Touma E. H., Charpentier C. Medium chain acyl-CoA dehydrogenase deficiency. Arch Dis Child. 1992; 67: 142–5
   PubMed Web of Science ®Google Scholar
• Treem W. R., Witzleben C. A., Piccoli C. A., et al. Medium-chain and long-chain acyl CoA dehydrogenase deficiency: clinical, pathologic, and ultrastructural differentiation from Reye's syndrome. Hepatology 1986; 6: 1270–8
   PubMed Web of Science ®Google Scholar
• Chitayat D. Sudden infant death and inherited disorders of fatty acid oxidation. Respiratory control disorders in infants and children, C. E. Hunt, R. T. Brouillette, R. C. Beckerman. Williams & Wilkins, Baltimore 1991; 277–293
   Google Scholar
• Howat A. J., Bennett M. J., Variend S., et al. Defects of metabolism of fatty acids in the sudden infant death syndrome. Br Med J. 1985; 290: 1771–3
   PubMedGoogle Scholar
• Greene C. L., Blitzer MG, Shapira E. Inborn errors of metabolism and Reye syndrome: differential diagnosis. J Pediatr. 1988; 113: 156–9
   PubMedGoogle Scholar
• Duran M., Hofkamp M., Rhead W. J., et al. Sudden child death and “healthy” affected family members with medium-chain acyl-coenzyme A dehydrogenase deficiency. Pediatrics 1986; 78: 1052–7
   PubMedGoogle Scholar
• Gregersen N., Koivraa S., Rasmussen K., et al. General (medium-chain) acyl-CoA dehydrogenase deficiency (non-ketotic dicarboxylic aciduria): quantitative urinary excretion pattern of 23 biologically significant organic acids in three cases. Clin Chim Acta. 1983; 132: 181–91
   PubMedGoogle Scholar
• Duran M., Wadman SKD. Chemical diagnosis of inherited defects of fatty acid metabolism and ketogenesis. Recent advances in inborn errors of metabolism, K. Tada, J. P. Colombo, R. J. Desnick. S. Karger, Basel 1987; 115–23
   Google Scholar
• Sweetman L., Hoffmann G, Aramaki S. New diagnostic techniques for the detection of organic acidemias. Recent advances in inborn errors of metabolism, K. Tada, J. P. Colombo, R. J. Desnick. S. Karger, Basel 1987; 124–31
   Google Scholar
• Duran M., Bruinvis L., Ketting D., et al. Cis-4-decenoic acid in plasma: a characteristic metabolite in medium chain acyl-CoA dehydrogenase deficiency. Clin Chem 1988; 34: 548–51
   PubMedGoogle Scholar
• Morton D. H., Kelley R. I. Diagnosis of medium-chain acyl-coenzyme A dehydrogenase deficiency in the neonatal period by measurement of medium-chain fatty acids in plasma and filter paper blood samples. J Pediatr. 1990; 117: 439–42
   PubMedGoogle Scholar
• Heales SJR, Woolf D. A., Robinson P., et al. Rapid diagnosis of medium-chain acyl-CoA dehydrogenase- deficiency by measurement of cw-4-decenoic acid in plasma. J. Inherited Metab Dis 1991; 14: 661–7
   PubMedGoogle Scholar
• Heales SJR, Leonard J. V. Diagnosis of medium-chain acyl CoA dehydrogenase deficiency by measurement of m-4-decenoic acid in dried blood spots. Clin Chim Acta. 1992; 209: 61–6
   PubMedGoogle Scholar
• Bennett M. J., Ragni M. C., Ostfeld R. J., et al. Population screening for medium-chain acyl CoA dehydrogenase deficiency: analysis of medium-chain fatty acids and acylglycines in blood spots. Ann Clin Biochem 1994; 31: 72–7
   PubMedGoogle Scholar
• Gregersen N., Andersen B. S., Bross P., et al. Molecular characterization of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: identification of a lys329to glu mutation in the MCAD gene, and expression of inactive mutant enzyme protein in E. coli. Hum Genet 1991; 86: 545–51
   PubMed Web of Science ®Google Scholar
• Curtis D., Blakemore A. F., Engel P. C., et al. Medium-chain acyl-CoA dehydrogenase deficiency in the United Kingdom. Prog Clin Biol Res 1992; 375: 489–94
   PubMedGoogle Scholar
• Koivraa S., Gregersen N., Blakemore A., et al. The most common mutation causing medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is strongly associated with a particular haplotype in the region of the gene. Hum Genet. 1991; 87: 425–9
   PubMedGoogle Scholar
• Lundemose J. B., Gregersen N., Koivraa N., et al. The frequency of a disease-causing point mutation in the gene coding for medium-chain acyl-CoA dehydrogenase in sudden infant death syndrome. Acta Pediatr. 1993; 82: 544–6
   PubMedGoogle Scholar
• Matsubara Y., Narisawa K., Tada K., et al. Prevalence of the K329E mutation in medium-chain acyl-CoA dehydrogenase gene determined from guthrie cards. Lancet. 1991; 338: 552–3
   PubMedGoogle Scholar
• Hale D. E., Stanley CA, Coates P. M. The long-chain acyl-CoA dehydrogenase deficiency. Prog Clin Biol Res. 1990; 321: 303–11
   PubMedGoogle Scholar
• Hale D. E., Batshaw M. L., Coates P. M., et al. Long-chain acyl coenzyme A dehydrogenase deficiency: an inherited cause of non-ketotic hypoglycemia. Pediatr Res 1985; 19: 666–71
   PubMed Web of Science ®Google Scholar
• Treem W. R., Stanley C. A., Hale D. E., et al. Hypoglycemia, hypotonia, and cardiomyopathy: the evolving clinical picture of long-chain acyl-CoA dehydrogenase deficiency. Pediatrics. 1991; 87: 328–33
   PubMedGoogle Scholar
• Amendt B. A., Breene C., Sweetman L., et al. Short-chain acyl-Coenzyme A dehydrogenase deficiency. Clinical and biochemical studies in two patients. J Clin Invest. 1987; 79: 1303–9
   PubMed Web of Science ®Google Scholar
• Coates P. M., Hale D. E., Finocchiaro G., et al. Genetic deficiency of short-chain acyl-coenzyme A dehydrogenase deficiency in cultured fibroblasts from a patient with muscle carnitine deficiency and severe skeletal muscle weakness. J Clin Invest 1988; 81: 171–5
   PubMed Web of Science ®Google Scholar
• Hoffmann G. F., Hunneman D. H., Jacobs C., et al. Progressive fatal pancytopenia, psychomotor retardation, and muscle carnitine deficiency in a child with ethylmalonic aciduria and ethylmalonic acidemia. J Inherited Metab Dis 1990; 13: 337–40
   PubMedGoogle Scholar
• Tumbull D. M., Bartlett K., Stevens D. L., et al. Short-chain acyl-CoA dehydrogenase deficiency associated with a lipid storage myopathy and secondary carnitine deficiency. N Engl J Med. 1984; 311: 1232–7
   PubMed Web of Science ®Google Scholar
• Carpenter K., Pollitt PJ, Middleton B. Human liver long-chain 3-hydroxyacyl-coenzyme A dehydrogenase is a multifunctional membrane-bound beta-oxidation enzyme of mitochondria. Biochem Biophys Res Commun. 1992; 183: 443–8
   PubMedGoogle Scholar
• Uchida Y., Izai K., Orii T., et al. Novel fatty acid β-oxidation enzymes in rat liver mitochondria. II. Purification and properties of enoyl-coenzyme A (CoA) hydratase/3-hydroxyacyI-CoA dehy-drogenase/3-ketoacyl-CoA thiolase trifunctional protein. J Biol Chem. 1992; 267: 1034–41
   PubMed Web of Science ®Google Scholar
• Duran M., Wanders RJA, De Jager J. P., et al. 3-Hydroxydicarboxylic aciduria due to long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency associated with sudden neonatal death: protective effect of medium-chain triglyceride treatment. Eur J Pediatr. 1991; 150: 190–5
   PubMedGoogle Scholar
• Hagenfeldt L., von Dobeln U., Holme E., et al. 3-Hydroxydicarboxylic aciduria – a fatty acid oxidation defect with severe prognosis. J Pediatr. 1990; 116: 387–92
   PubMedGoogle Scholar
• Glasgow A. M., Engel A. G., Bier D. M., et al. Hypoglycemia, hepatic dysfunction, muscle weakness, cardiomyopathy, free carnitine deficiency and long-chain acylcarnitine excess responsive to medium chain triglyceride diet. Pediatr Res 1983; 17: 319–26
   PubMed Web of Science ®Google Scholar
• Jackson S., Bartlett K., Land J., et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Pediatr Res 1991; 29: 406–11
   PubMed Web of Science ®Google Scholar
• Pollitt R. J. Clinical and biochemical presentation in 20 cases of hydroxydicarbocyclic aciduria. Prog Clin Biol Res 1990; 321: 495–502
   PubMedGoogle Scholar
• Wanders RJA, Ijlst L., van Gennip A. H., et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: identification of a new inborn error of mitochondrial fatty acid p-oxidation. J Inherited Metab Dis 1990; 13: 311–4
   PubMed Web of Science ®Google Scholar
• Rocchiccioli F., Wanders RJA, Aubourg P., et al. Deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase: a cause of lethal myopathy and cardiomyopathy in early childhood. Pediatr Res 1990; 28: 657–62
   PubMed Web of Science ®Google Scholar
• Bertini E., Sabatelli M., Garavaglia B., et al. Myopathy and sensory-motor polyneuropathy in long chain 3-OH-acyl CoA dehydrogenase deficiency. J Neurol Sci 1990; 98(Suppl)273
   Google Scholar
• Dionisi-Vici C. D., Burlina A. B., Bertini E., et al. Progressive neuropathy and recurrent myoglobinuria in a child with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. J Pediatr. 1991; 118: 744–6
   PubMedGoogle Scholar
• Jackson S., Kler R. S., Bartlett K., et al. Combined enzyme defect of mitochondrial fatty acid oxidation. J Clin Invest 1992; 90: 1219–25
   PubMedGoogle Scholar
• Treem W. R., Rinaldo P., Hale D. E., et al. Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Hepatology 1994; 19: 339–45
   PubMed Web of Science ®Google Scholar
• Wilcken B., Leung K. C., Hammond J., et al. Pregnancy and fetal long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency. Lancet. 1993; 341: 407–8
   PubMedGoogle Scholar
• Tein I., De Vivo D. C., Hale D. E., et al. Short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency in muscle: a new cause for recurrent myoglobinuria and encephalopathy. Ann Neurol 1991; 30: 415–9
   PubMedGoogle Scholar
• Bergoffen J., Kaplan P., Hale D. E., et al. Marked elevation of urinary 3-hydroxydecanedioic acid in a malnourished infant with glycogen storage disease, mimicking long-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency. J Inherited Metab Dis 1993; 16: 851–6
   PubMedGoogle Scholar
• Bennett M. J., Weinberger M. J., Sherwood W. G., et al. Secondary 3-hydroxydicarboxylic aciduria mimicking long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. J Inherited Metab Dis 1994; 17: 283–6
   PubMedGoogle Scholar
• La Du B. N., Gjessing L. R. Tyrosinosis and tyrosinemia. The molecular basis of inherited disease, J. B. Stanbury, J. B. Wyngaarden, D. S. Fredrickson. McGraw-Hill, New York 1978; 256
   Google Scholar
• Giardini O., Cantani A., Kennaway N. G., et al. Chronic tyrosinemia associated with 4-hydroxyphenylpyruvate dioxigenase deficiency with acute intermittent ataxia and without visceral bone involvement. Pediatr Res 1983; 17: 25–9
   PubMedGoogle Scholar
• Endo F., Kitano A., Uehara I., et al. 4-Hydroxyphenylpyruvic acid oxidase deficiency with normal fumarylacetoacetase: a new variant form of hereditary hypertyrosinemia. Pediatr Res 1983; 17: 92–6
   PubMedGoogle Scholar
• Goldsmith L. A., Laberge C. Tyrosinemia and related disorders. The metabolic basis of inherited disease, C. R. Scriver, A. L. Beaudet, W. S. Sly, et al. McGraw-Hill, New York 1989; 572–62
   Google Scholar
• La Du, Alcaptonuria B. N. The metabolic basis of inherited disease, C. R. Scriver, A. L. Beaudet, W. S. Sly, et al. McGraw-Hill, New York 1989; 775–90
   Google Scholar
• Tada K., Yokoyama Y., Nakagawa H., et al. Vitamin B6dependent xanthurenic aciduria. Tohoku J Exp Med 1967; 93: 115–24
   PubMedGoogle Scholar
• Komrower G. M., Wilson V., Clamp J. R., et al. Hydroxykynureinuria. A case of abnormal tryptophane metabolism probably due to a deficiency of kynureninase. Arch Dis Child 1964; 39: 250–6
   PubMedGoogle Scholar
• Cohen R. D., Woods H. F. Clinical and biochemical aspects of lactic acidosis. Blackwell Scientific, Oxford 1976
   Google Scholar
• Teyssier G. Carbohydrate infusion inducing lactic acidosis. Role of thiamine in an infant with malnutrition. Presse Med. 1986; 15: 120–1
   PubMedGoogle Scholar
• Saudubray J-M, Barbier M-L. Thiamine. Les vitamines, A. Munnich, M. Ogier, J-M Saudubray. Masson, Paris 1987; 107–42
   Google Scholar
• Stacpoole P. W. Lactic acidosis. Endocrinol Metab Clin North Am 1993; 22: 221–45
   PubMed Web of Science ®Google Scholar
• Pettersen J. E., Landaas S., Eldjarn L. The occurrence of 2-hydroxybutyric acid in urine from patients with lactic acidosis. Clin Chim Acta 1973; 48: 213–9
   PubMedGoogle Scholar
• Mason P. D. Metabolic acidosis due to D-lactate. Br Med J. 1986; 292: 1105–6
   PubMedGoogle Scholar
• Hudson M., Pocknee R, Mowat NAG. D-Lactic acidosis in short bowel syndrome – an examination of possible mechanisms. Q J Med 1990; 74: 157–63
   PubMedGoogle Scholar
• Gurevitch J., Sela B., Jonas A., et al. D-Lactic acidosis: a treatable encephalopathy in pediatric patients. Acta Pediatr 1993; 82: 119–21
   PubMedGoogle Scholar
• Thum J. R., Pierpont G. L., Ludvigsen C. W., et al. D-Lactate encephalopathy. Am J Med 1985; 79: 717–21
   PubMedGoogle Scholar
• Meister A., Larsson A. Glutathione synthetase deficiency and other disorders of the gamma-glutamyl cycle. The metabolic basis of inherited disease, C. R. Scriver, A. L. Beaudet, WS Sly, et al. McGraw-Hill, New York 1989; 855–68
   Google Scholar
• Pitt JJ, Brown G. K., Clift V., et al. Atypical pyroglutamic aciduria: possible role of paracetamol. J Inherited Metab Dis 1990; 13: 755–6
   PubMed Web of Science ®Google Scholar
• Bonham J. R., Rattenburg J. M., Meeks A., et al. Pyroglutamic aciduria from vigabatrin. Lancet. 1989; 1: 1452–3
   PubMedGoogle Scholar
• Hoffmann G. F., Charpentier C., Mayatepek E., et al. Clinical and biochemical phenotype in 11 patients with mevalonic aciduria. Pediatrics 1993; 91: 915–21
   PubMed Web of Science ®Google Scholar
• Niederwieser A., Wadman SK, Danks D. M. Excretion of cis- and trans-4-hydroxycyclohexylacetic acid in addition to hawkinsin in a family with a postulated defect of 4-hydroxyphenylpyruvate dioxygenase. Clin Chim Acta 1978; 90: 195–200
   PubMed Web of Science ®Google Scholar
• Wilcken B., Hammond J. W., Howard N., et al. Hawkinsinuria. A dominantly inherited defect of tyrosine metabolism wim severe effects in infancy. N Engl J Med. 1981; 305: 865–9
   PubMedGoogle Scholar
• Cotariu D., Zaidman J. L. Valproic acid and the liver. Clin Chem 1988; 34: 890–7
   PubMed Web of Science ®Google Scholar
• Becker C. M., Harris R. A. Influence of valproic acid on hepatic carbohydrate and lipid metabolism. Arch Biochem Biophys. 1983; 223: 381–92
   PubMed Web of Science ®Google Scholar
• Kukino K., Mineura K., Deguchi T., et al. Studies on a new anticonvulsant drug, sodium dipropylacetate. Assay for metabolites and metabolic pathway. J Pharm Soc Jpn 1972; 92: 869–900
   Google Scholar
• Abbott F. S., Kassam J., Orr J. M., et al. The effect of aspirin on valproic acid metabolism. Clin Pharmacol Ther 1986; 40: 94–100
   PubMed Web of Science ®Google Scholar
• Anderson G. D., Acheampong AA, Levy R. H. Interaction between valproate and branched-chain amino acid metabolism. Neurology 1994; 44: 742–4
   PubMed Web of Science ®Google Scholar
• Turnbull D. M., Bone A. J., Bartlett K., et al. The effects of valproate on intermediary metabolism in isolated hepatocytes and intact rats. Biochem Pharmacol 1983; 32: 1887–92
   PubMed Web of Science ®Google Scholar
• Ohtani Y., Endo F, Matsuda I. Carnitine deficiency and hyperammonemia associated with valproic acid therapy. J Pediatr 1982; 101: 782–5
   PubMed Web of Science ®Google Scholar
• Thurston J. H., Caroll J. E., Dodson W. E., et al. Chronic valproate administration reduces fasting ketonemia in children. Neurology 1983; 33: 1348–50
   PubMedGoogle Scholar
• Rettie A. E., Rettenmeier A. W., Howald W. N., et al. Cytochrome P-450-catalyzed formation of 4-en-VPA, a toxic metabolite of valproic acid. Science 1987; 235: 890–3
   PubMed Web of Science ®Google Scholar
• Granneman GR, Wang S. I., Kesterton J. W., et al. The hepatotoxicity of valproic acid and its metabolites in rats. II. Intermediary and valproic acid metabolism. Hepatology 1984; 4: 1153–8
   PubMed Web of Science ®Google Scholar
• Dreifuss F. E., Santilli N., Langer D. H., et al. Valproic acid hepatic fatalities. A retrospective review. Neurology 1987; 37: 379–85
   PubMed Web of Science ®Google Scholar
• Rettenmeier A. W., Howald W. N., Levy R. H., et al. Quantitative metabolic profiling of valproic acid in humans using automated gas chromatographic/mass spectrometric techniques. Biomed Environ Mass Spectrom 1989; 18: 192–9
   PubMedGoogle Scholar
• Bartlett K. Sodium valproate and hyperglycinaemia, [Letter]. Lancet. 1977; 2: 716
   PubMedGoogle Scholar
• Cherruau B., Mangeot M., Demelier J. F., et al. Metabolic abnormalities observed in the rat after administration of sodium dipropylacetate. Toxicol Lett. 1981; 8: 39–42
   PubMedGoogle Scholar
• Schmidt-Sommerfeld E., Perm D., Rinaldo P., et al. Urinary medium-chain acylcarnitines in medium-chain acyl-CoA dehydrogenase deficiency, medium-chain triglyceride feeding and valproic acid therapy: sensitivity and specificity of the radioisotopic exchange/high performance liquid chromatography method. Pediatr Res 1992; 31: 545–51
   PubMedGoogle Scholar
• Kossak B. D., Schmidt-Sommerfeld E., Scholler D. A., et al. Impaired fatty acid oxidation in children on valproic acid and the effect of L-carnitine. Neurology 1993; 43: 2362–8
   PubMed Web of Science ®Google Scholar
• Coulter D. L., Allen R. J. Hyperammonemia with valproic acid therapy. J Pediatr 1981; 99: 317–9
   PubMedGoogle Scholar
• Coude F., Rabier D., Cathelineau L., et al. A mechanism for valproate-induced hyperammonemia. Pediatr Res 1981; IS: 974–5
   Google Scholar
• Melegh B., Kerner J, Bieber L. L. Pivampicillin-promoted excretion of pivaloylcarnitine in humans. Biochem Pharmacol 1987; 36: 3405–9
   PubMed Web of Science ®Google Scholar
• Holme E., Jacobson C. E., Nordin I., et al. Carnitine deficiency induced by pivampicillin and pivmecillinam therapy. Lancet. 1989; 2: 469–73
   PubMed Web of Science ®Google Scholar
• Selby P. L., Sherratt HSA. Substituted 2-oxiranecarboxylic acids: a new group of cardidate hypoglycaemic drugs. Trends Pharmacol Sci 1989; 10: 495–500
   PubMed Web of Science ®Google Scholar
• Wolf HPO. Aryl-substituted 2-oxiranecarboxylic acids: a new group of antidiabetic drugs. New antidiabetic drugs, C. J. Bailey, P. R. Flatt. Smith-Gordon, London 1990; 217–227
   Google Scholar
• Kler R. S., Sherratt HSA, Turnbull D. M., et al. Organic aciduria in fasted rats caused by 2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate (etomoxir). Biochem Pharmacol 1991; 42: 1637–9
   PubMedGoogle Scholar
• Melde K., Jackson S., Bartlett K., et al. Metabolic consequences of methylenecyclopropylglycine poisoning in rats. Biochem. J. 1991; 274: 395–400
   PubMedGoogle Scholar
• Veitch R. K., Sherratt HSA. Organic aciduria in rats made resistant to hypoglycin toxicity by pretreatment with clofibrate. Biochem J 1987; 246: 775–8
   PubMedGoogle Scholar
• Tanaka K., Miller EM, Isselbacher K. J. Hypogycin a: a specific inhibitor of isovaleryl CoA dehydrogenase. Proc Natl Acad Sci USA 1971; 68: 20–4
   PubMedGoogle Scholar
• Rhead W. J., Tanaka K. Demonstration of a specific mitochondrial isovaleryl-CoA dehydrogenase deficiency in fibroblasts from patients with isovaleric acidemia. Proc Natl Acad Sci USA 1980; 77: 580–3
   PubMedGoogle Scholar
• Hine D. G., Tanaka K. Capillary gas chromatographic/mass spectrometric analysis of abnormal metabolites in hypoglycin-treated rat urine. Biomed Mass Spectrom. 1984; 11: 332–9
   PubMedGoogle Scholar
• Giordano G., Murray W. J., Previs S. F., et al. Identification of 2-(2'-octenylsuccinic) acid in urine. Rapid Commun Mass Spectrom. 1990; 4: 170–2
   PubMedGoogle Scholar
• Kelley R. I. Octenylsuccinic aciduria in children fed protein-hydrolysate formulas containing modified cornstarch. Pediatr Res. 1991; 30: 564–9
   PubMedGoogle Scholar
• Giordano G., McMurray W. J., Previs S. F., et al. Identification of 2-(2'octenylsuccinic) acid metabolites in urine by GC/MS and GC/MS/MS. Proceeding of the 40th ASMS Conference on Mass Spectrometry and Allied Topics, Washington, DC May 31-June 5, 1992 910–11. May 31-June 5, 1992
   Google Scholar
• McGarry J. D., Foster D. W. Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem 1980; 49: 395–420
   PubMed Web of Science ®Google Scholar
• Mortensen P. B., Gregersen N. Medium-chain triglyceride medication as a pitfall in the diagnosis of non-ketotic C6-C10-dicarboxylic acidurias. Clin Chim Acta. 1980; 103: 33–7
   PubMedGoogle Scholar
• Shigematsu Y., Momoi T., Sudo M., et al. (ω-l)-Hydroxymonocarboxylic acids in urine of infants fed medium-chain triglycerides. Clin Chem 1981; 27: 1661
   PubMedGoogle Scholar
• Brass E. P., Tserng K.Y, Eckel R. H. Urinary organic acid excretion during feeding of medium-chain or long-chain triglyceride diets in patients with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1990; 52: 923–6
   PubMed Web of Science ®Google Scholar
• Rubaltelli F. F., Orzali A., Rinaldo P., et al. Carnitine and the premature. Biol Neonate 1987; 52(Suppl 1)65–77
   PubMedGoogle Scholar
• Kuhara T., Matsumoto I., Ohno M., et al. Identification and quantification of octanoyl glucu-ronide in the urine of children who ingested medium-chain triglycerides. Biomed Environ Mass Spectrom. 1986; 13: 595–8
   PubMedGoogle Scholar
• Norman E. J. New urinary methylmalonic acid test is a sensitive indicator of cobalamine (vitamin Bl2) deficiency: a solution for a major unrecognized medical problem. J Lab Clin Med 1987; 110: 369–70
   PubMed Web of Science ®Google Scholar
• Ledley F. D., Levy H. L., Shih V. E., et al. Benign methylmalonic aciduria. N Engl J Med. 1984; 311: 1015–8
   PubMedGoogle Scholar
• Carmen R., Sinow RM, Kamaze D. S. Atypical cobalamine deficiency. J Lab Clin Med. 1987; 109: 454–63
   PubMedGoogle Scholar
• Higginbottom M. C., Sweetman L, Nyhan W. L. A syndrome of methylmalonic aciduria, homocystinuria, megaloblastic anemia and neurologic abnormalities in a vitamin B12-deficient breast-fed infant of a strict vegetarian. N Engl J Med. 1979; 299: 317–23
   Google Scholar
• Specker B. L., Miller D., Norman E. J., et al. Increased urinary methylmalonic acid excretion in breast-fed infants of vegetarian mothers and identification of an acceptable dietary source of vitamin B-12. Am J Clin Nutr 1988; 47: 89–92
   PubMedGoogle Scholar
• Close G. C. Rastafarianism and the vegans syndrome. Br Med J 1983; 286: 473
   PubMedGoogle Scholar
• Goodman S. I. Organic aciduria in the riboflavin deficient rat. Am J Clin Nutr 1981; 34: 2434–7
   PubMedGoogle Scholar
• Gregersen N., Kolvraa S. The occurrence of C6-C0-dicarboxylic acids, ethylmalonic acid, 5-hydroxycaproic acid, butyrylglycine, isovalerylglycine, isobutyrylglycine, 2-methyl-butyrylglycine and glutaric acid in the urine of riboflavin-deficient rats. J Inherited Metab Dis 1982; 5(Suppl 1)17–18
   PubMedGoogle Scholar
• Gromisch D. S., Lopez R., Cole H. S., et al. Light (phototherapy)-induced riboflavin deficiency in the neonate. J Pediatr. 1977; 90: 118–22
   PubMedGoogle Scholar
• Tan K. L., Chow MT, Karim SMM. Effect of phototherapy on neonatal riboflavin status. J Pediatr. 1978; 93: 494–7
   PubMedGoogle Scholar
• Amin H. J., Shukla A. K., Snyder F., et al. Significance of phototherapy-induced riboflavin deficiency in the full-term neonate. Biol Neonate 1992; 61: 76–81
   PubMedGoogle Scholar
• Oriot D., Wood C., Gottesman R., et al. Severe lactic acidosis related to acute thiamine deficiency. J Parenter Enter Nutr 1991; 15: 105–9
   PubMedGoogle Scholar
• Penn D, Ludwigs B, Schmidt-Sommerfeld E., et al. Effect of nutrition on tissue carnitine concentrations in infants of different gestational ages. Biol Neonate 1985; 47: 130–5
   PubMedGoogle Scholar
• Penn D, Schmidt-Sommerfeldt E, Wolf H. Carnitine deficiency in premature infants receiving total parenteral nutrition. Early Hum Dev. 1980; 4: 23–34
   PubMedGoogle Scholar
• Schmidt-Sommerfeldt E., Penn D., Bieber L. L., et al. Carnitine ester excretion in pediatric patients receiving parenteral nutrition. Pediatr Res 1990; 28: 158–65
   PubMedGoogle Scholar
• Schmidt-Sommerfeld E., Penn D. Role of carnitine in children receiving total parenteral nutrition. L-Carnitine and its role in medicine, R. Ferrari, S. Dimauro, G. Sherwood. Academic Press, London 1992; 117–36
   Google Scholar
• Worthley L. I., Fishlock RC, Snoswel A. M. Carnitine balance and effects of intravenous L-carnitine in two patients receiving long-term parenteral nutrition. J Parenter Enter Nutr. 1983; 8: 717–9
   Google Scholar
• Pichard C., Roulet M., Schutz Y., et al. Clinical relevance of L-camitine-supplemented total parenteral nutrition in post-operative trauma. Am J Clin Nutr 1989; 49: 283–9
   PubMedGoogle Scholar
• Iapichino G., Radrizzani D., Colombo A., et al. Carnitine excretion: a catabolic index of injury. J Parenter Enteral Nutr. 1988; 12: 35–6
   PubMedGoogle Scholar
• Nanni G., Pittirut M., Giovannini I., et al. Plasma carnitine levels and urinary carnitine excretion during sepsis. J Parenter Enter Nutr. 1985; 9: 483–90
   PubMed Web of Science ®Google Scholar
• Cummings J. H. Fermentation in the human large intestine: evidence and implication for health. Lancet 1983; 1: 1206–9
   PubMed Web of Science ®Google Scholar
• Mortensen P. B., Holtug K., Bonnen H., et al. The degradation of amino acids, proteins, and blood to short-chain fatty acids in colon is prevented by lactulose. Gastroenterology 1990; 98: 353–60
   PubMed Web of Science ®Google Scholar
• McNeil N. I., Cummings JH, James WPT. Short chain fatty acid absorption by the human large intestine. Gut. 1978; 19: 819–22
   PubMed Web of Science ®Google Scholar
• Williams R. T. Toxicologic implications of biotransformation by intestinal microflora. Toxicol Appl Pharmacol 1972; 23: 769–81
   PubMed Web of Science ®Google Scholar
• Zieve L., Nicoloff D. M. Pathogenesis of hepatic coma. Annu Rev Med. 1975; 26: 143–57
   PubMed Web of Science ®Google Scholar
• Zieve L. The mechanism of hepatic coma. Hepatology 1981; 1: 360–5
   PubMed Web of Science ®Google Scholar
• Walter J. H., Leonard J. V., Thompson G. N., et al. Gut bacterial metabolism. Lancet. 1988; 2: 226
   PubMedGoogle Scholar
• Pollitt R. J., Fowler B., Sardharwalla I. B., et al. Increased excretion of propan-l,3-diol and 3-hydroxypropionic acid apparently caused by abnormal bacterial metabolism in the gut. Clin ChimActa. 1987; 169: 151–8
   PubMedGoogle Scholar
• Bain M. D., Jones M., Boriello S. P., et al. Contribution of gut bacterial metabolism to human metabolic disease. Lancet 1988; 1: 1078–9
   PubMedGoogle Scholar
• Rinaldo P., O'Shea J. J., Welch R. D., et al. The enzymatic basis for the dehydrogenation of 3-phenylpropionic acid:. in vitro reaction of 3-phenylpropionyl-CoA with various acyl-CoA dehydrogenases. Pediatr Res. 1990; 27: 501–7
   PubMed Web of Science ®Google Scholar
• Permutter D. H., Boyle J. T., Compos J. M. D-Lactic acidosis in children: an unusual metabolic complication of small bowel resection. J Pediatr. 1983; 102: 234–8
   PubMedGoogle Scholar
• Schoorel E. P., Giesbets MAH, Blom W., et al. D-Lactic acidosis in a boy with short bowel syndrome. Arch Dis Child 1980; 55: 810–2
   PubMed Web of Science ®Google Scholar
• Haan E., Brown G., Bankier A., et al. Severe illness caused by the products of bacterial metabolism in a child with a short gut. Eur J Pediatr. 1985; 144: 63–5
   PubMedGoogle Scholar
• McCabe ERB, Goodman S. I., Fennessey P. V., et al. Glutaric, 3-hydroxypropionic and lactic aciduria with metabolic acidemia, following extensive small bowel resection. Biochim Med 1982; 28: 229–36
   PubMedGoogle Scholar
• Kay M. A., O'Brien W., Kessler B., et al. Transient organic aciduria and methemoglobinemia with acute gastroenteritis. Pediatrics 1990; 85: 589–92
   PubMedGoogle Scholar
• Walker V., Mills G. A. Urinary organic acid excretion by babies born before 33 weeks of gestation. Clin Chem 1989; 35: 1460–6
   PubMedGoogle Scholar
• Rebouche C. J. Recent advances in carnitine biosynthesis and transport. Clinical aspects of human carnitine deficiency, P. Borum. Pergamon Press, New York 1986; 1–15
   Google Scholar
• Ahmad S. Carnitine, kidney and renal dialysis. L-CAMITINE AND ITS ROLE IN MEDICINE, R. Ferrari, S. Dimauro, G. Sherwood. Academic Press, London 1992; 381–400
   Google Scholar
• Walker V., Mills G. A. Effects of birth asphyxia on urinary organic acid excretion. Biol Neonate 1992; 61: 162–72
   PubMedGoogle Scholar
• Ogier H., Charpentier C, Saudubray J-M. Organic acidemias. Inborn metabolic diseases: diagnosis and treatment, J. Femandes, J-M Saudubray, K. Tada. Springer-Verlag, Berlin 1990; 271–99
   Google Scholar